您的位置: 首页 > 农业专利 > 详情页

AMINOALKYL-SUBSTITUTED N-THIENYLBENZAMIDE DERIVATIVE
专利权人:
ASTELLAS PHARMA INC.
发明人:
MIURA, MASANORI,三浦理宪,三浦理憲,KAGA, DAISUKE,加贺大辅,加賀大輔,WATANUKI, SUSUMU,四月朔日晋,四月朔日晉,HACHIYA, SHUNICHIRO,八谷俊一郎,八谷俊一郎,OKUDA, TAKAO,奥田崇男,奧田崇男,SATO, IPPEI,佐藤一平,佐藤一平,ISOMURA, MAI,矶村真衣,磯村真衣,TERAI, KAZUHIRO,寺居和宏
申请号:
TW101139423
公开号:
TW201323419A
申请日:
2012.10.25
申请国别(地区):
TW
年份:
2013
代理人:
摘要:
[Problem] To provide a compound that has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia.[Means for Solution] The present inventors conducted thier studies on a compound that has an NPT-IIb inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia. As a result, they created an aminoalkyl-substituted N-thienylbenzamide derivative which has NPT-IIb, inhibitory action, thereby completing the present invention. The aminoalkyl-substituted N-thienylbenzamide derivative of the present invention has an NPT-IIb inhibitory action and can be used as an agent for preventing and/or treating hyperphosphatemia.提供一種具有腸磷酸鹽轉運子(NPT-IIb)抑制作用且可用作為高磷酸鹽血症之治療及/或預防劑的活性成分之化合物。本發明人對具有NPT-IIb抑制作用且可用作為高磷酸鹽血症之治療及/或預防劑之活性成分的化合物進行研究。結果,產生一種具有NPT-IIb抑制作用的經胺基烷基取代之N-噻吩基苯甲醯胺衍生物,因而完成本發明。本發明之經胺基烷基取代之N-噻吩基苯甲醯胺衍生物具有NPT-IIb抑制作用且可用作為高磷酸鹽血症之治療及/或預防劑。
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充